Targeted microbubbles have been conjugated to ligands specific for highly expressed molecular markers of tumor angiogenesis such as VEGFR-2 and αvβ3-integrin [64,65,68,70] to allow for the assessment of tumor angiogenic activity and for monitoring anti-angiogenic therapies in preclinical tumor models [90-92]. This evidence concerns the gene KDR and neoplasm.